Evidence map›Paper›PMID 31456076›Full record

ArticleLangenbeck's archives of surgery2019

Single cohort study: ABO-incompatible kidney transplant recipients have a higher risk of lymphocele formation.

Bernd Martin Jänigen, Chiara Salabè, Torben Glatz, Oliver Thomusch, Claudia Lässle, Stefan Fichtner-Feigl, Stefan Zschiedrich, Przemyslaw Pisarski

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Langenbeck's archives of surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Non-antigen-specific Immunoadsorption Is a Risk Factor for Severe Postoperative Infections in ABO-Incompatible Kidney Transplant Recipients.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Bernd Martin JänigenDepartment of General and Digestive Surgery, Section of Transplant Surgery, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg im Breisgau, Germany. bernd.jaenigen@uniklinik-freiburg.de.ORCID http://orcid.org/0000-0001-9401-8815
Chiara SalabèDepartment of General and Digestive Surgery, Section of Transplant Surgery, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg im Breisgau, Germany.
Torben GlatzDepartment of General and Digestive Surgery, Section of Transplant Surgery, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg im Breisgau, Germany.
Oliver ThomuschDepartment of General and Digestive Surgery, Section of Transplant Surgery, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg im Breisgau, Germany.
Claudia LässleDepartment of General and Digestive Surgery, Section of Transplant Surgery, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg im Breisgau, Germany.
Stefan Fichtner-FeiglDepartment of General and Digestive Surgery, Section of Transplant Surgery, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg im Breisgau, Germany.
Stefan ZschiedrichDepartment of Medicine IV, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg im Breisgau, Germany.
Przemyslaw PisarskiDepartment of General and Digestive Surgery, Section of Transplant Surgery, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg im Breisgau, Germany.
University of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSince 2004, ABO-incompatible kidney transplantation (ABOi KTx) became an established procedure to expand the living donor pool in Germany. Currently, ABOi KTx comprises > 20% of all living donor KTx. Up to September 2015, > 100 ABOi KTx were performed in Freiburg. Regarding lymphocele formation, only scarce data exist.

methodsBetween April 2004 and September 2015, 106 consecutive ABOi and 277 consecutive ABO-compatible kidney transplantations (ABOc KTx) were performed. Two ABOi and 117 ABOc recipients were excluded due to differences in immunosuppression. One hundred-four ABOi and 160 ABOc KTx patients were analyzed concerning lymphocele formation.

resultsThe incidence of lymphoceles in ABOi KTx was 25.2% and 10.6% in ABOc KTx (p = 0.003). A major risk factor appeared the frequency of ≥ 8 preoperative immunoadsorption and/or plasmapheresis sessions (OR 5.61, 95% CI 2.31-13.61, p < 0.001). Particularly, these ABOi KTx recipients had a distinctly higher risk of developing lymphocele (40.0% vs. 19.2%, p = 0.044). IA/PE sessions on day of transplantation (no lymphocele 20.0% vs. lymphocele 28.6%, p = 0.362) or postoperative IA/PE sessions (no lymphocele 25.7% vs. lymphocele 24.1%, p = 1.0) showed no influence on formation of lymphoceles.

conclusionIn ABOi KTx, the incidence of lymphocele formation is significantly increased compared to ABOc KTx and leads to more frequent surgical reinterventions without having an impact on graft survival.

Indexed as

ABO Blood-Group SystemBlood Group IncompatibilityCohort StudiesFemaleFollow-Up StudiesGermanyGraft RejectionGraft SurvivalHumansIncidenceKidney TransplantationLiving DonorsLogistic ModelsLymphoceleMaleMultivariate AnalysisABO Blood-Group SystemABO-incompatible kidney transplantationBlood group-incompatibilityImmunoadsorptionRenal transplantationSurgical complications

Identifiers

PMID31456076
OpenAlexW2971289229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.